BioCentury
ARTICLE | Company News

Upsher-Smith sales and marketing update

July 21, 2014 7:00 AM UTC

Upsher-Smith launched Qudexy XR topiramate extended-release capsules in the U.S. for seizures. Specifically, the drug is indicated as initial monotherapy in patients ages 10 years or older with parti...